Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000909625 | SCV001054441 | benign | not provided | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000909625 | SCV001753431 | benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002260107 | SCV002539527 | benign | Bohring-Opitz syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004958265 | SCV005502350 | likely benign | Inborn genetic diseases | 2024-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |